Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells

Protein phosphatase magnesium‐dependent 1B (PPM1B) functions as IKKβ phosphatases to terminate nuclear factor kappa B (NF‐κB) signaling. NF‐κB signaling was constitutively activated in glioma cells. At present, little is known about the role of PPM1B in glioma. In the current study, we found that th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell biology international 2024-02, Vol.48 (2), p.143-153
Hauptverfasser: Yu, Yunhu, Liu, Qian, Ran, Qishan, Cao, Fang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 153
container_issue 2
container_start_page 143
container_title Cell biology international
container_volume 48
creator Yu, Yunhu
Liu, Qian
Ran, Qishan
Cao, Fang
description Protein phosphatase magnesium‐dependent 1B (PPM1B) functions as IKKβ phosphatases to terminate nuclear factor kappa B (NF‐κB) signaling. NF‐κB signaling was constitutively activated in glioma cells. At present, little is known about the role of PPM1B in glioma. In the current study, we found that the expression of PPM1B was reduced in glioma tissues and cells, and decreased expression of PPM1B was related to poor overall survival of patients. Overexpression of PPM1B inhibited the proliferation and promoted apoptosis of glioma cells. Moreover, PPM1B overexpression reduced the phosphorylation of IKKβ and inhibited the nuclear localization of NF‐κBp65. PDTC, an inhibitor of NF‐κB signaling, reversed PPM1B‐knockdown‐induced cell proliferation. Furthermore, overexpression of PPM1B enhanced the sensitivity of glioma cells to temozolomide. In vivo experiments showed that overexpression of PPM1B could inhibit tumor growth, improve the survival rate of nude mice, and enhance the sensitivity to temozolomide. In conclusion, PPM1B suppressed glioma cell proliferation and the IKKβ‐NF‐κB signaling pathway, and enhanced temozolomide sensitivity of glioma cells.
doi_str_mv 10.1002/cbin.12092
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2874260849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2915387909</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3572-32d6abb388cc890bbbfc60b82f7a761a97305a0f360fc7daf435a34f05e3d3dc3</originalsourceid><addsrcrecordid>eNp9kMlKxTAUhoMozhsfQAJuRKhmaJpk6b04gdNC1yFJE420zTXpdXp6W6-6cOHqHM75-Pj5AdjB6BAjRI6sCd0hJkiSJbCOkWSFoIwtj3vFikpKtgY2cn5CCONSVKtgjXIuhSzxOrA3Ly65t1lyOYfYwejh7e0VnsDQPQYTeldD--jaOPxD7nVnHewj7IfLR2xiG2oHdVfDWYpN8C7pfpSEDj40IbYaWtc0eQuseN1kt_09N8H96cnd9Ly4vDm7mB5fFpYyTgpK6kobQ4WwVkhkjPG2QkYQzzWvsJacIqaRpxXyltfal5RpWnrEHK1pbekm2F94hzTPc5d71YY8JtCdi_OsiOAlqZAo5YDu_UGf4jx1QzpFJGZUcIlG6mBB2RRzTs6rWQqtTu8KIzVWr8bq1Vf1A7z7rZyb1tW_6E_XA4AXwGto3Ps_KjWdXFwvpJ9-n49U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2915387909</pqid></control><display><type>article</type><title>Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yu, Yunhu ; Liu, Qian ; Ran, Qishan ; Cao, Fang</creator><creatorcontrib>Yu, Yunhu ; Liu, Qian ; Ran, Qishan ; Cao, Fang</creatorcontrib><description>Protein phosphatase magnesium‐dependent 1B (PPM1B) functions as IKKβ phosphatases to terminate nuclear factor kappa B (NF‐κB) signaling. NF‐κB signaling was constitutively activated in glioma cells. At present, little is known about the role of PPM1B in glioma. In the current study, we found that the expression of PPM1B was reduced in glioma tissues and cells, and decreased expression of PPM1B was related to poor overall survival of patients. Overexpression of PPM1B inhibited the proliferation and promoted apoptosis of glioma cells. Moreover, PPM1B overexpression reduced the phosphorylation of IKKβ and inhibited the nuclear localization of NF‐κBp65. PDTC, an inhibitor of NF‐κB signaling, reversed PPM1B‐knockdown‐induced cell proliferation. Furthermore, overexpression of PPM1B enhanced the sensitivity of glioma cells to temozolomide. In vivo experiments showed that overexpression of PPM1B could inhibit tumor growth, improve the survival rate of nude mice, and enhance the sensitivity to temozolomide. In conclusion, PPM1B suppressed glioma cell proliferation and the IKKβ‐NF‐κB signaling pathway, and enhanced temozolomide sensitivity of glioma cells.</description><identifier>ISSN: 1065-6995</identifier><identifier>EISSN: 1095-8355</identifier><identifier>DOI: 10.1002/cbin.12092</identifier><identifier>PMID: 37798941</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Animals ; Apoptosis ; Cell growth ; Cell Line, Tumor ; Cell Proliferation ; Chemoresistance ; Drug Resistance, Neoplasm ; Glioma ; Glioma - metabolism ; Glioma cells ; Humans ; I-kappa B Kinase - metabolism ; IKKβ‐NF‐κB ; Localization ; Magnesium ; Mice ; Mice, Nude ; NF-kappa B - metabolism ; Phosphoprotein Phosphatases ; Phosphorylation ; PPM1B ; proliferation ; Protein phosphatase ; Protein Phosphatase 2C ; Signal transduction ; Temozolomide ; Temozolomide - pharmacology ; temozolomide resistance</subject><ispartof>Cell biology international, 2024-02, Vol.48 (2), p.143-153</ispartof><rights>2023 International Federation of Cell Biology.</rights><rights>2024 International Federation for Cell Biology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3572-32d6abb388cc890bbbfc60b82f7a761a97305a0f360fc7daf435a34f05e3d3dc3</citedby><cites>FETCH-LOGICAL-c3572-32d6abb388cc890bbbfc60b82f7a761a97305a0f360fc7daf435a34f05e3d3dc3</cites><orcidid>0000-0002-4900-8957</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcbin.12092$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcbin.12092$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37798941$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Yunhu</creatorcontrib><creatorcontrib>Liu, Qian</creatorcontrib><creatorcontrib>Ran, Qishan</creatorcontrib><creatorcontrib>Cao, Fang</creatorcontrib><title>Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells</title><title>Cell biology international</title><addtitle>Cell Biol Int</addtitle><description>Protein phosphatase magnesium‐dependent 1B (PPM1B) functions as IKKβ phosphatases to terminate nuclear factor kappa B (NF‐κB) signaling. NF‐κB signaling was constitutively activated in glioma cells. At present, little is known about the role of PPM1B in glioma. In the current study, we found that the expression of PPM1B was reduced in glioma tissues and cells, and decreased expression of PPM1B was related to poor overall survival of patients. Overexpression of PPM1B inhibited the proliferation and promoted apoptosis of glioma cells. Moreover, PPM1B overexpression reduced the phosphorylation of IKKβ and inhibited the nuclear localization of NF‐κBp65. PDTC, an inhibitor of NF‐κB signaling, reversed PPM1B‐knockdown‐induced cell proliferation. Furthermore, overexpression of PPM1B enhanced the sensitivity of glioma cells to temozolomide. In vivo experiments showed that overexpression of PPM1B could inhibit tumor growth, improve the survival rate of nude mice, and enhance the sensitivity to temozolomide. In conclusion, PPM1B suppressed glioma cell proliferation and the IKKβ‐NF‐κB signaling pathway, and enhanced temozolomide sensitivity of glioma cells.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Chemoresistance</subject><subject>Drug Resistance, Neoplasm</subject><subject>Glioma</subject><subject>Glioma - metabolism</subject><subject>Glioma cells</subject><subject>Humans</subject><subject>I-kappa B Kinase - metabolism</subject><subject>IKKβ‐NF‐κB</subject><subject>Localization</subject><subject>Magnesium</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>NF-kappa B - metabolism</subject><subject>Phosphoprotein Phosphatases</subject><subject>Phosphorylation</subject><subject>PPM1B</subject><subject>proliferation</subject><subject>Protein phosphatase</subject><subject>Protein Phosphatase 2C</subject><subject>Signal transduction</subject><subject>Temozolomide</subject><subject>Temozolomide - pharmacology</subject><subject>temozolomide resistance</subject><issn>1065-6995</issn><issn>1095-8355</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMlKxTAUhoMozhsfQAJuRKhmaJpk6b04gdNC1yFJE420zTXpdXp6W6-6cOHqHM75-Pj5AdjB6BAjRI6sCd0hJkiSJbCOkWSFoIwtj3vFikpKtgY2cn5CCONSVKtgjXIuhSzxOrA3Ly65t1lyOYfYwejh7e0VnsDQPQYTeldD--jaOPxD7nVnHewj7IfLR2xiG2oHdVfDWYpN8C7pfpSEDj40IbYaWtc0eQuseN1kt_09N8H96cnd9Ly4vDm7mB5fFpYyTgpK6kobQ4WwVkhkjPG2QkYQzzWvsJacIqaRpxXyltfal5RpWnrEHK1pbekm2F94hzTPc5d71YY8JtCdi_OsiOAlqZAo5YDu_UGf4jx1QzpFJGZUcIlG6mBB2RRzTs6rWQqtTu8KIzVWr8bq1Vf1A7z7rZyb1tW_6E_XA4AXwGto3Ps_KjWdXFwvpJ9-n49U</recordid><startdate>202402</startdate><enddate>202402</enddate><creator>Yu, Yunhu</creator><creator>Liu, Qian</creator><creator>Ran, Qishan</creator><creator>Cao, Fang</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4900-8957</orcidid></search><sort><creationdate>202402</creationdate><title>Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells</title><author>Yu, Yunhu ; Liu, Qian ; Ran, Qishan ; Cao, Fang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3572-32d6abb388cc890bbbfc60b82f7a761a97305a0f360fc7daf435a34f05e3d3dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Chemoresistance</topic><topic>Drug Resistance, Neoplasm</topic><topic>Glioma</topic><topic>Glioma - metabolism</topic><topic>Glioma cells</topic><topic>Humans</topic><topic>I-kappa B Kinase - metabolism</topic><topic>IKKβ‐NF‐κB</topic><topic>Localization</topic><topic>Magnesium</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>NF-kappa B - metabolism</topic><topic>Phosphoprotein Phosphatases</topic><topic>Phosphorylation</topic><topic>PPM1B</topic><topic>proliferation</topic><topic>Protein phosphatase</topic><topic>Protein Phosphatase 2C</topic><topic>Signal transduction</topic><topic>Temozolomide</topic><topic>Temozolomide - pharmacology</topic><topic>temozolomide resistance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Yunhu</creatorcontrib><creatorcontrib>Liu, Qian</creatorcontrib><creatorcontrib>Ran, Qishan</creatorcontrib><creatorcontrib>Cao, Fang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cell biology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Yunhu</au><au>Liu, Qian</au><au>Ran, Qishan</au><au>Cao, Fang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells</atitle><jtitle>Cell biology international</jtitle><addtitle>Cell Biol Int</addtitle><date>2024-02</date><risdate>2024</risdate><volume>48</volume><issue>2</issue><spage>143</spage><epage>153</epage><pages>143-153</pages><issn>1065-6995</issn><eissn>1095-8355</eissn><abstract>Protein phosphatase magnesium‐dependent 1B (PPM1B) functions as IKKβ phosphatases to terminate nuclear factor kappa B (NF‐κB) signaling. NF‐κB signaling was constitutively activated in glioma cells. At present, little is known about the role of PPM1B in glioma. In the current study, we found that the expression of PPM1B was reduced in glioma tissues and cells, and decreased expression of PPM1B was related to poor overall survival of patients. Overexpression of PPM1B inhibited the proliferation and promoted apoptosis of glioma cells. Moreover, PPM1B overexpression reduced the phosphorylation of IKKβ and inhibited the nuclear localization of NF‐κBp65. PDTC, an inhibitor of NF‐κB signaling, reversed PPM1B‐knockdown‐induced cell proliferation. Furthermore, overexpression of PPM1B enhanced the sensitivity of glioma cells to temozolomide. In vivo experiments showed that overexpression of PPM1B could inhibit tumor growth, improve the survival rate of nude mice, and enhance the sensitivity to temozolomide. In conclusion, PPM1B suppressed glioma cell proliferation and the IKKβ‐NF‐κB signaling pathway, and enhanced temozolomide sensitivity of glioma cells.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37798941</pmid><doi>10.1002/cbin.12092</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-4900-8957</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1065-6995
ispartof Cell biology international, 2024-02, Vol.48 (2), p.143-153
issn 1065-6995
1095-8355
language eng
recordid cdi_proquest_miscellaneous_2874260849
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Apoptosis
Cell growth
Cell Line, Tumor
Cell Proliferation
Chemoresistance
Drug Resistance, Neoplasm
Glioma
Glioma - metabolism
Glioma cells
Humans
I-kappa B Kinase - metabolism
IKKβ‐NF‐κB
Localization
Magnesium
Mice
Mice, Nude
NF-kappa B - metabolism
Phosphoprotein Phosphatases
Phosphorylation
PPM1B
proliferation
Protein phosphatase
Protein Phosphatase 2C
Signal transduction
Temozolomide
Temozolomide - pharmacology
temozolomide resistance
title Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A47%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overexpression%20of%20PPM1B%20inhibited%20chemoresistance%20to%20temozolomide%20and%20proliferation%20in%20glioma%20cells&rft.jtitle=Cell%20biology%20international&rft.au=Yu,%20Yunhu&rft.date=2024-02&rft.volume=48&rft.issue=2&rft.spage=143&rft.epage=153&rft.pages=143-153&rft.issn=1065-6995&rft.eissn=1095-8355&rft_id=info:doi/10.1002/cbin.12092&rft_dat=%3Cproquest_cross%3E2915387909%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2915387909&rft_id=info:pmid/37798941&rfr_iscdi=true